|
Q2 FY2027
As of Aug 1, 2026
|
Q1 FY2027
As of May 2, 2026
|
Q4 FY2026
As of Jan 31, 2026
|
Q3 FY2026
As of Oct 25, 2025
|
Q2 FY2026
As of Jul 26, 2025
|
Q1 FY2026
As of Apr 26, 2025
|
Q4 FY2025
As of Jan 25, 2025
|
Q3 FY2025
As of Oct 26, 2024
|
Q2 FY2025
As of Jul 27, 2024
|
Q1 FY2025
As of Apr 27, 2024
|
Q4 FY2024
As of Jan 27, 2024
|
Q3 FY2024
As of Oct 28, 2023
|
Q2 FY2024
As of Jul 29, 2023
|
Q1 FY2024
As of Apr 29, 2023
|
Q4 FY2023
As of Jan 28, 2023
|
Q3 FY2023
As of Oct 29, 2022
|
Q2 FY2023
As of Jul 30, 2022
|
Q1 FY2023
As of Apr 30, 2022
|
Q4 FY2022
As of Jan 29, 2022
|
Q3 FY2022
As of Oct 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and equivalents | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Contract assets | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Income tax receivable | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Current portion of debt | ||||||||||||||||||||
| Contract liabilities | ||||||||||||||||||||
| Accrued insurance claims | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Income taxes payable | ||||||||||||||||||||
| Other accrued liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Accrued insurance claims - non-current | ||||||||||||||||||||
| Operating lease liabilities - non-current | ||||||||||||||||||||
| Deferred tax liabilities, net - non-current | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Preferred stock, par value $1.00 per share: 1,000,000 shares authorized: no shares issued and outstanding | ||||||||||||||||||||
| Common stock, par value $0.33 1/3 per share: 150,000,000 shares authorized: 30,155,100 and 29,969,648 issued and outstanding, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
| Common stock, shares outstanding | ||||||||||||||||||||
| Common stock, authorized (in shares) | ||||||||||||||||||||
| Common stock, par value (in dollars per share) |
Loading...
